Literature DB >> 23257733

Role of glucose-6-phosphate and xylulose-5-phosphate in the regulation of glucose-stimulated gene expression in the pancreatic β cell line, INS-1E.

Katsumi Iizuka1, Wudelehu Wu, Yukio Horikawa, Jun Takeda.   

Abstract

Whether glucose-6-phosphate (G6P) or xylulose-5-phosphate (X5P) is the signaling molecule for carbohydrate response element binding protein (ChREBP) transactivation has been controversial. In this study, we tested the role of G6P and X5P in the regulation of ChREBP transactivation in the pancreatic β cell line, INS-1E. In contrast to glucose, which can be converted into both G6P and X5P, 2DG is only converted into 2DG6P. The potency of 2-deoxy-glucose (2DG) to induce Chrebp target mRNA was weaker and less persistent than that of glucose. Moreover, the results from siRNA knockdown of ChREBP, a reporter assay involving the pGL3 promoter with carbohydrate response element (ChoRE), and a ChIP assay with an anti-ChREBP antibody revealed that 2DG does not increase ChREBP transactivity in INS-1E cells. In accordance with these results, transfection of siRNA against Chrebp tended to reduce glucose-stimulated, but not 2DG-stimulated, expression of ChREBP target genes. Conversely, the expression of xylulokinase (Xylb), which converts xylitol to X5P, was much lower than in primary hepatocytes. In INS-1E cells infected by adenovirus bearing Xylb cDNA, xylitol increased expression of ChREBP target genes, although with a weaker potency than glucose. Finally, X5P partly induced ChREBP transactivity in INS-1E cells overexpressing Xylb cDNA. In conclusion, G6P and X5P can activate ChREBP transactivity, but their potencies to induce ChREBP transactivity were much lower than that of glucose, suggesting that other factors such as fructose 2,6-bisphosphate may be needed for full activation of glucose-induced gene expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23257733

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  12 in total

1.  HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP.

Authors:  Elizabeth A Lane; Dong Wook Choi; Luisa Garcia-Haro; Zebulon G Levine; Meghan Tedoldi; Suzanne Walker; Nika N Danial
Journal:  Mol Cell       Date:  2019-06-18       Impact factor: 17.970

2.  The polyol pathway is an evolutionarily conserved system for sensing glucose uptake.

Authors:  Hiroko Sano; Akira Nakamura; Mariko Yamane; Hitoshi Niwa; Takashi Nishimura; Kimi Araki; Kazumasa Takemoto; Kei-Ichiro Ishiguro; Hiroki Aoki; Yuzuru Kato; Masayasu Kojima
Journal:  PLoS Biol       Date:  2022-06-10       Impact factor: 9.593

Review 3.  Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP.

Authors:  Xu Xu; Jae-Seon So; Jong-Gil Park; Ann-Hwee Lee
Journal:  Semin Liver Dis       Date:  2013-11-12       Impact factor: 6.115

Review 4.  From Food to Genes: Transcriptional Regulation of Metabolism by Lipids and Carbohydrates.

Authors:  Inés Bravo-Ruiz; Miguel Ángel Medina; Beatriz Martínez-Poveda
Journal:  Nutrients       Date:  2021-04-30       Impact factor: 5.717

5.  Dietary Macronutrient Composition Directs ChREBP Isoform Expression and Glucose Metabolism in Mice.

Authors:  Tara Jois; Victor Howard; Kristina Youngs; Michael A Cowley; Mark W Sleeman
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

Review 6.  The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism.

Authors:  Katsumi Iizuka
Journal:  Nutrients       Date:  2017-02-22       Impact factor: 5.717

Review 7.  Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism.

Authors:  Ho-Jae Lee; Ji-Young Cha
Journal:  BMB Rep       Date:  2018-09       Impact factor: 4.778

8.  Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer.

Authors:  Akash K Kaushik; Ali Shojaie; Katrin Panzitt; Rajni Sonavane; Harene Venghatakrishnan; Mohan Manikkam; Alexander Zaslavsky; Vasanta Putluri; Vihas T Vasu; Yiqing Zhang; Ayesha S Khan; Stacy Lloyd; Adam T Szafran; Subhamoy Dasgupta; David A Bader; Fabio Stossi; Hangwen Li; Susmita Samanta; Xuhong Cao; Efrosini Tsouko; Shixia Huang; Daniel E Frigo; Lawrence Chan; Dean P Edwards; Benny A Kaipparettu; Nicholas Mitsiades; Nancy L Weigel; Michael Mancini; Sean E McGuire; Rohit Mehra; Michael M Ittmann; Arul M Chinnaiyan; Nagireddy Putluri; Ganesh S Palapattu; George Michailidis; Arun Sreekumar
Journal:  Nat Commun       Date:  2016-05-19       Impact factor: 14.919

9.  ChREBP Regulates Itself and Metabolic Genes Implicated in Lipid Accumulation in β-Cell Line.

Authors:  Chanachai Sae-Lee; Kanya Moolsuwan; Lawrence Chan; Naravat Poungvarin
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

10.  FMK, an Inhibitor of p90RSK, Inhibits High Glucose-Induced TXNIP Expression via Regulation of ChREBP in Pancreatic β Cells.

Authors:  Jung-Hwa Han; Suji Kim; Sujin Kim; Heejung Lee; So-Young Park; Chang-Hoon Woo
Journal:  Int J Mol Sci       Date:  2019-09-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.